IL112114A - 1,1-Dioxo-1,22-H-benzothiazinoylguanidines, process for their preparation and pharmaceutical preparations containing them - Google Patents
1,1-Dioxo-1,22-H-benzothiazinoylguanidines, process for their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL112114A IL112114A IL11211494A IL11211494A IL112114A IL 112114 A IL112114 A IL 112114A IL 11211494 A IL11211494 A IL 11211494A IL 11211494 A IL11211494 A IL 11211494A IL 112114 A IL112114 A IL 112114A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- treatment
- production
- medicament
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
- Photoreceptors In Electrophotography (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4344550A DE4344550A1 (de) | 1993-12-24 | 1993-12-24 | Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen |
Publications (2)
Publication Number | Publication Date |
---|---|
IL112114A0 IL112114A0 (en) | 1995-03-15 |
IL112114A true IL112114A (en) | 2001-06-14 |
Family
ID=6506276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11211494A IL112114A (en) | 1993-12-24 | 1994-12-22 | 1,1-Dioxo-1,22-H-benzothiazinoylguanidines, process for their preparation and pharmaceutical preparations containing them |
Country Status (20)
Country | Link |
---|---|
US (1) | US5547953A (fr) |
EP (1) | EP0659748B1 (fr) |
JP (1) | JP3790559B2 (fr) |
KR (2) | KR100360127B1 (fr) |
CN (1) | CN1053899C (fr) |
AT (1) | ATE194605T1 (fr) |
AU (1) | AU683320B2 (fr) |
CA (1) | CA2138466A1 (fr) |
DE (2) | DE4344550A1 (fr) |
DK (1) | DK0659748T3 (fr) |
ES (1) | ES2149233T3 (fr) |
FI (1) | FI946039A (fr) |
GR (1) | GR3034335T3 (fr) |
HU (1) | HU222524B1 (fr) |
IL (1) | IL112114A (fr) |
NO (1) | NO304787B1 (fr) |
NZ (2) | NZ272846A (fr) |
PT (1) | PT659748E (fr) |
TW (1) | TW504505B (fr) |
ZA (1) | ZA9410242B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0765867A1 (fr) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Benzoylguanidines substituées, procédé de leur préparation, leur utilisation comme agent antiarythmique ou diagnostique ainsi que le médicament les contenant |
DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PL316439A1 (en) * | 1995-11-20 | 1997-05-26 | Hoechst Ag | Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such |
DE19546736A1 (de) * | 1995-12-14 | 1997-06-19 | Hoechst Ag | Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate |
DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
CA2195697A1 (fr) | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Derives substitues de la guanidine, procede pour leur obtention et leurs utilisations pharmaceutiques |
JPH10152481A (ja) * | 1996-09-25 | 1998-06-09 | Kanebo Ltd | ベンゾ[1,4]チアジン誘導体およびそれからなる医薬 |
ES2224365T3 (es) * | 1997-02-12 | 2005-03-01 | Smithkline Beecham Corporation | Antagonistas de receptores de il-8. |
US6436927B1 (en) | 1997-02-12 | 2002-08-20 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
CA2283404A1 (fr) | 1997-03-06 | 1998-09-11 | Jun Sasamori | Derives de cycloalca¬b|pyridine-3-carbonylguanidine, leur procede de production et medicaments les contenant |
JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のNa▲上+▼/H▲上+▼交換の阻害剤としてのグアニジン誘導体 |
US6703405B2 (en) | 2001-12-22 | 2004-03-09 | Aventis Pharma Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them |
DE10163914A1 (de) * | 2001-12-22 | 2003-07-03 | Aventis Pharma Gmbh | Substituierte 4-Phenyltetrahydroisochinolinium-Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
WO2006044645A2 (fr) * | 2004-10-13 | 2006-04-27 | Adolor Corporation | Sulfamoyle benzamides et procedes d'utilisation |
CN103476252B (zh) | 2010-12-08 | 2017-02-22 | 莱斯拉公司 | 吡唑基胍f1f0‑atp酶抑制剂及其治疗用途 |
JP6050242B2 (ja) | 2010-12-08 | 2016-12-21 | リセラ・コーポレイションLycera Corporation | ピリドニルグアニジンf1f0−atpアーゼ阻害剤およびその治療的使用 |
US9169199B2 (en) | 2010-12-08 | 2015-10-27 | Lycera Corporation | Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof |
EP2866796A4 (fr) | 2012-06-08 | 2015-11-25 | Lycera Corp | Inhibiteurs d' atpase de type f1f0, à base de guanidine d'indazole |
WO2013185046A1 (fr) | 2012-06-08 | 2013-12-12 | Lycera Corporation | Guanidine d'acyle saturée pour inhibition de l'atpase de type f1f0 |
EP2866893A4 (fr) | 2012-06-08 | 2015-12-23 | Lycera Corp | Inhibiteurs d' atpase de type f1f0, à base de guanidine hétérocyclique et leurs utilisations thérapeutiques |
WO2015089152A1 (fr) | 2013-12-10 | 2015-06-18 | Lycera Corporation | Inhibiteurs de la f1fo-atpase à base de pyrazolyl guanidine à subsitution n et applications thérapeutiques associées |
JP2016539983A (ja) | 2013-12-10 | 2016-12-22 | リセラ・コーポレイションLycera Corporation | アルキルピラゾリルグアニジンf1f0−atpアーゼ阻害剤及びその治療用途 |
AU2014363904B2 (en) | 2013-12-10 | 2018-10-04 | Lycera Corporation | Trifluoromethyl pyrazolyl guanidine F1Fo-ATPase inhibitors and therapeutic uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3780027A (en) * | 1970-04-29 | 1973-12-18 | Merck & Co Inc | Anthranilic acid derivatives |
DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
EP0556674B1 (fr) * | 1992-02-15 | 1996-06-19 | Hoechst Aktiengesellschaft | Benzoylguanidines 3,5-substitués avec une activité antiarrhythmique et une activité inhibitrice de la prolifération des cellules |
ES2097409T3 (es) * | 1992-09-22 | 1997-04-01 | Hoechst Ag | Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos. |
EP0590455B1 (fr) * | 1992-09-28 | 2000-12-27 | Hoechst Aktiengesellschaft | 1-(2H)-Isoquinoleines substituées à activité antiarrythmique et cardioprotective, procédé de préparation, médicaments les contenant et leur utilisation pour la préparation de médicaments pour traiter l'insuffisance cardiaque |
TW250479B (fr) * | 1992-12-15 | 1995-07-01 | Hoechst Ag |
-
1993
- 1993-12-24 DE DE4344550A patent/DE4344550A1/de not_active Withdrawn
-
1994
- 1994-11-21 TW TW083110790A patent/TW504505B/zh not_active IP Right Cessation
- 1994-12-19 PT PT94120069T patent/PT659748E/pt unknown
- 1994-12-19 EP EP94120069A patent/EP0659748B1/fr not_active Expired - Lifetime
- 1994-12-19 DK DK94120069T patent/DK0659748T3/da active
- 1994-12-19 ES ES94120069T patent/ES2149233T3/es not_active Expired - Lifetime
- 1994-12-19 AT AT94120069T patent/ATE194605T1/de not_active IP Right Cessation
- 1994-12-19 DE DE59409439T patent/DE59409439D1/de not_active Expired - Lifetime
- 1994-12-19 CA CA002138466A patent/CA2138466A1/fr not_active Abandoned
- 1994-12-22 JP JP31959294A patent/JP3790559B2/ja not_active Expired - Fee Related
- 1994-12-22 HU HU9403759A patent/HU222524B1/hu not_active IP Right Cessation
- 1994-12-22 FI FI946039A patent/FI946039A/fi not_active Application Discontinuation
- 1994-12-22 US US08/362,003 patent/US5547953A/en not_active Expired - Lifetime
- 1994-12-22 IL IL11211494A patent/IL112114A/en not_active IP Right Cessation
- 1994-12-22 ZA ZA9410242A patent/ZA9410242B/xx unknown
- 1994-12-22 CN CN94119193A patent/CN1053899C/zh not_active Expired - Fee Related
- 1994-12-22 NZ NZ272846A patent/NZ272846A/en unknown
- 1994-12-22 NZ NZ270264A patent/NZ270264A/en unknown
- 1994-12-22 AU AU81700/94A patent/AU683320B2/en not_active Ceased
- 1994-12-23 NO NO944747A patent/NO304787B1/no unknown
- 1994-12-24 KR KR1019940036497A patent/KR100360127B1/ko not_active IP Right Cessation
-
2000
- 2000-09-06 GR GR20000402023T patent/GR3034335T3/el not_active IP Right Cessation
-
2002
- 2002-03-25 KR KR1020020016125A patent/KR100353339B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUT72749A (en) | 1996-05-28 |
FI946039A (fi) | 1995-06-25 |
ZA9410242B (en) | 1995-08-02 |
DE4344550A1 (de) | 1995-06-29 |
KR950017981A (ko) | 1995-07-22 |
NO945015D0 (no) | 1994-12-23 |
IL112114A0 (en) | 1995-03-15 |
JPH07206823A (ja) | 1995-08-08 |
JP3790559B2 (ja) | 2006-06-28 |
DE59409439D1 (de) | 2000-08-17 |
EP0659748A1 (fr) | 1995-06-28 |
DK0659748T3 (da) | 2000-10-02 |
FI946039A0 (fi) | 1994-12-22 |
PT659748E (pt) | 2000-11-30 |
NZ270264A (en) | 1996-02-27 |
US5547953A (en) | 1996-08-20 |
EP0659748B1 (fr) | 2000-07-12 |
CA2138466A1 (fr) | 1995-06-25 |
HU222524B1 (hu) | 2003-08-28 |
AU8170094A (en) | 1995-06-29 |
NO304787B1 (no) | 1999-02-15 |
CN1053899C (zh) | 2000-06-28 |
NO945015L (no) | 1995-06-26 |
AU683320B2 (en) | 1997-11-06 |
KR100360127B1 (ko) | 2003-04-23 |
HU9403759D0 (en) | 1995-02-28 |
ES2149233T3 (es) | 2000-11-01 |
KR100353339B1 (ko) | 2002-09-19 |
NZ272846A (en) | 1996-02-27 |
CN1107840A (zh) | 1995-09-06 |
ATE194605T1 (de) | 2000-07-15 |
TW504505B (en) | 2002-10-01 |
GR3034335T3 (en) | 2000-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5547953A (en) | Substituted 1-oxo-1,2-dihydroisoquinolinoylguanidines and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them | |
CA2130944C (fr) | Derives de substitution en ortho de benzoylguanidines; methode de preparation; utilisation en pharmacie ou en diagnostic; produit pharmaceutique a base de ces derives | |
CA2089439C (fr) | Benzoylguanidines a substituant en 3,5, procede d'obtention et emploi comme medicament ou diagnostique, et medicament qui les contient | |
JP3802582B2 (ja) | ペルフルオロアルキル−置換ベンゾイルグアニジン類、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬 | |
US6025349A (en) | Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them | |
US5516805A (en) | 3,5-substituted aminobenzoylguanidines, their use as a medicament or diagnostic and medicament containing them | |
US5747541A (en) | Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them | |
US6632840B1 (en) | Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them | |
JPH08259515A (ja) | 塩基で置換されたベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬 | |
CZ218496A3 (en) | Substituted guanidines of cinnamic acid, process of their preparation, their use as a medicament or a diagnostic agent, as well as the medicament in which they are comprised | |
IL110625A (en) | Benzoylguanidines are converted in urea, the process for their preparation and the seafood preparations containing them | |
RU2160727C2 (ru) | Бензоилгуанидины, способ их получения, промежуточное соединение для их получения, способ ингибирования и лекарственное средство | |
CA2152878A1 (fr) | Derives de substitution de benzoylguanidines, amines en ortho; methode de preparation; utilisation comme medicaments ou agents de diagnostic; medicaments renfermant ces derives | |
CA2206758C (fr) | Benzoylguanidines ortho-substituees, procede de preparation, leur utilisation comme medicament ou produit diagnostique et medicament contenant ces composes | |
US6156800A (en) | 4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
US5856344A (en) | Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them | |
CA2206362C (fr) | 1-naphthoylguanidines de substitution, processus de preparation de celles-ci, leur utilisation comme medicament ou a des fins diagnostiques et medicament les renfermant | |
US5869531A (en) | Fluoroalkyl substituted benzoylguanidines | |
JPH08225514A (ja) | 置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬 | |
CZ65497A3 (cs) | Ortho-substituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiva a léčiva, která je obsahují | |
MXPA97001323A (en) | Benzoilguanidinas replaced in orthodous position, a procedure for its preparation, its use as a diagnostic medicine or agent, so i composed that conti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |